mecamylamine has been researched along with Hyperventilation in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Hyperventilation: A pulmonary ventilation rate faster than is metabolically necessary for the exchange of gases. It is the result of an increased frequency of breathing, an increased tidal volume, or a combination of both. It causes an excess intake of oxygen and the blowing off of carbon dioxide.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guvenc-Bayram, G | 1 |
| Yalcin, M | 1 |
1 other study available for mecamylamine and Hyperventilation
| Article | Year |
|---|---|
The involvement of the central cholinergic system in the hyperventilation effect of centrally injected nesfatin-1 in rats.
Topics: Animals; Atropine; Blood Gas Analysis; Carbon Dioxide; Hyperventilation; Injections, Intraventricula | 2021 |